Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0043124
DC FieldValue
dc.titleToll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease
dc.contributor.authorBudulac S.E.
dc.contributor.authorBoezen H.M.
dc.contributor.authorHiemstra P.S.
dc.contributor.authorLapperre T.S.
dc.contributor.authorVonk J.M.
dc.contributor.authorTimens W.
dc.contributor.authorPostma D.S.
dc.contributor.authorKauffman H.F.
dc.contributor.authorde Reus D.
dc.contributor.authorJansen D.F.
dc.contributor.authorBarentsen M.D.W.
dc.contributor.authorZeinstra-Smit M.
dc.contributor.authorLuteijn A.J.
dc.contributor.authorvan der Molen T.
dc.contributor.authorter Veen G.
dc.contributor.authorGosman M.M.E.
dc.contributor.authorten Hacken N.H.T.
dc.contributor.authorKerstjens H.A.M.
dc.contributor.authorvan Maaren M.S.
dc.contributor.authorVeltman C.A.
dc.contributor.authorVerbokkem A.
dc.contributor.authorVerhage I.
dc.contributor.authorVink-Klooster H.K.
dc.contributor.authorSnoeck-Stroband J.B.
dc.contributor.authorThiadens H.
dc.contributor.authorSont J.K.
dc.contributor.authorBajema I.
dc.contributor.authorGast-Strookman J.
dc.contributor.authorJanssen K.
dc.contributor.authorRabe K.F.
dc.contributor.authorvan Schadewijk A.
dc.contributor.authorSmit-Bakker J.
dc.contributor.authorStolk J.
dc.contributor.authorTire' A.C.J.A.
dc.contributor.authorvan der Veen H.
dc.contributor.authorWijffels M.M.E.
dc.contributor.authorWillems L.N.A.
dc.contributor.authorSterk P.J.
dc.contributor.authorMauad T.
dc.date.accessioned2020-03-18T05:44:32Z
dc.date.available2020-03-18T05:44:32Z
dc.date.issued2012
dc.identifier.citationBudulac S.E., Boezen H.M., Hiemstra P.S., Lapperre T.S., Vonk J.M., Timens W., Postma D.S., Kauffman H.F., de Reus D., Jansen D.F., Barentsen M.D.W., Zeinstra-Smit M., Luteijn A.J., van der Molen T., ter Veen G., Gosman M.M.E., ten Hacken N.H.T., Kerstjens H.A.M., van Maaren M.S., Veltman C.A., Verbokkem A., Verhage I., Vink-Klooster H.K., Snoeck-Stroband J.B., Thiadens H., Sont J.K., Bajema I., Gast-Strookman J., Janssen K., Rabe K.F., van Schadewijk A., Smit-Bakker J., Stolk J., Tire' A.C.J.A., van der Veen H., Wijffels M.M.E., Willems L.N.A., Sterk P.J., Mauad T. (2012). Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease. PLoS ONE 7 (8) : e43124. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0043124
dc.identifier.issn19326203
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/165567
dc.description.abstractToll-like receptors (TLRs) participate in the defence against bacterial infections that are common in patients with Chronic Obstructive Pulmonary Disease (COPD). We studied all tagging SNPs in TLR2 and TLR4 and their associations with the level and change over time of both FEV1 and sputum inflammatory cells in moderate-to-severe COPD. Nine TLR2 SNPs and 17 TLR4 SNPs were genotyped in 110 COPD patients. Associations of SNPs with lung function and inflammatory cells in induced sputum were analyzed cross-sectionally with linear regression and longitudinally with linear mixed-effect models. Two SNPs in TLR2 (rs1898830 and rs11938228) were associated with a lower level of FEV1 and accelerated decline of FEV1 and higher numbers of sputum inflammatory cells. None of the TLR4 SNPs was associated with FEV1 level. Eleven out of 17 SNPs were associated with FEV1 decline, including rs12377632 and rs10759931, which were additionally associated with higher numbers of sputum inflammatory cells at baseline and with increase over time. This is the first longitudinal study showing that tagging SNPs in TLR2 and TLR4 are associated with the level and decline of lung function as well as with inflammatory cell numbers in induced sputum in COPD patients, suggesting a role in the severity and progression of COPD. © 2012 Budulac et al.
dc.publisherPublic Library of Science
dc.sourceUnpaywall 20200320
dc.subjecttoll like receptor 2
dc.subjecttoll like receptor 4
dc.subjectadult
dc.subjectarticle
dc.subjectchronic obstructive lung disease
dc.subjectcontrolled study
dc.subjectcross-sectional study
dc.subjectdisease severity
dc.subjecteosinophil count
dc.subjectfemale
dc.subjectforced expiratory volume
dc.subjectgene activation
dc.subjectgene expression regulation
dc.subjectgene frequency
dc.subjectgenetic analysis
dc.subjectgenetic association
dc.subjectgenetic variability
dc.subjectheterozygote
dc.subjecthomozygote
dc.subjecthuman
dc.subjectinflammatory cell
dc.subjectlung alveolus macrophage
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmolecular pathology
dc.subjectneutrophil count
dc.subjectreceptor gene
dc.subjectsingle nucleotide polymorphism
dc.subjectsputum analysis
dc.subjecttoll like receptor 2 gene
dc.subjecttoll like receptor 4 gene
dc.subjectBacteria (microorganisms)
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1371/journal.pone.0043124
dc.description.sourcetitlePLoS ONE
dc.description.volume7
dc.description.issue8
dc.description.pagee43124
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0043124.pdf1.1 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.